Molina Healthcare (MOH) Q1 2025 Earnings
Reported Apr 23, 2025 at 4:18 PM ET · SEC Source
Q1 25 EPS
$6.08
BEAT +2.05%
Est. $5.96
Q1 25 Revenue
$11.15B
BEAT +3.08%
Est. $10.81B
vs S&P Since Q1 25
-67.8%
TRAILING MARKET
MOH -29.7% vs S&P +38.1%
Market Reaction
Did MOH Beat Earnings? Q1 2025 Results
Molina Healthcare kicked off 2025 with a solid first quarter, posting adjusted earnings per share of $6.08 against a consensus estimate of $5.96, a beat of 2.05%, while revenue of $11.15 billion cleared expectations by 3.08% and grew 12.2% from a yea… Read more Molina Healthcare kicked off 2025 with a solid first quarter, posting adjusted earnings per share of $6.08 against a consensus estimate of $5.96, a beat of 2.05%, while revenue of $11.15 billion cleared expectations by 3.08% and grew 12.2% from a year ago. The top-line expansion was fueled primarily by premium revenue climbing to $10.63 billion from $9.50 billion, reflecting new contract wins, the ConnectiCare acquisition, and rate increases across the company's Medicaid and Marketplace footprints. Marketplace membership nearly doubled to 662,000 from 346,000, though the segment's medical care ratio widened to 81.7% from 73.3%, partly due to prior-year risk adjustment items and costs absorbed from ConnectiCare. Even as elevated Medicaid utilization in pharmacy and behavioral health nudged the consolidated MCR slightly higher, management held its full-year 2025 guidance firm, targeting adjusted EPS of at least $24.50 and premium revenue of roughly $42 billion. With CEO Joe Zubretsky signaling continued appetite for acquisitions, particularly among smaller single-state operators, the company appears focused on sustaining its long-term 13% to 15% adjusted EPS growth trajectory.
Key Takeaways
- • New contract wins and acquisitions driving 12% premium revenue growth
- • Disciplined medical cost management in an improving rate environment
- • G&A ratio improved to 6.9% from 7.2% due to operating leverage
- • Marketplace membership nearly doubled year over year to 662,000
- • Medicare pricing and benefit adjustments improved Medicare MCR to 88.3%
- • New rate cycle offset higher Medicaid utilization in long-term services, pharmacy, and behavioral health
MOH YoY Financials
Q1 2025 vs Q1 2024, source: SEC Filings
MOH Revenue by Segment
With YoY comparisons, source: SEC Filings
“Our first quarter results reflect our team's disciplined approach to medical cost management in an improving rate environment. Our 2025 earnings and growth profiles are solid, and we remain confident in our ability to achieve our 13% to 15% long-term adjusted EPS growth target.”
— Joseph Zubretsky, Q1 2025 Earnings Press Release
MOH Earnings Trends
MOH vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
MOH EPS Trend
Earnings per share: estimate vs actual
MOH Revenue Trend
Quarterly revenue: estimate vs actual
MOH Quarterly Results
4 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q4 25 MISS FY | $0.33 | $-2.75 | -921.63% | $11.38B | +4.31% |
| FY Full Year | $13.93 | $11.03 | -20.80% | $45.43B | +1.02% |
| Q3 25 MISS | $3.89 | $1.84 | -52.73% | $11.48B | +4.49% |
| Q2 25 MISS | $5.53 | $5.48 | -0.93% | $11.43B | +4.44% |
| Q1 25 BEAT | $5.96 | $6.08 | +2.05% | $11.15B | +3.08% |